ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 49 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,501 | -84.7% | 17,511 | -86.2% | 0.00% | -100.0% |
| Q2 2023 | $1,308,901 | +1049.4% | 127,325 | +763.2% | 0.00% | – |
| Q1 2023 | $113,877 | +90.0% | 14,751 | +80.9% | 0.00% | – |
| Q4 2022 | $59,939 | +3.3% | 8,155 | +1.3% | 0.00% | – |
| Q3 2022 | $58,000 | -24.7% | 8,049 | -11.4% | 0.00% | – |
| Q2 2022 | $77,000 | +35.1% | 9,089 | +44.3% | 0.00% | – |
| Q1 2022 | $57,000 | -41.8% | 6,300 | -10.5% | 0.00% | – |
| Q4 2021 | $98,000 | +38.0% | 7,042 | +5.4% | 0.00% | – |
| Q3 2021 | $71,000 | -94.1% | 6,680 | -95.0% | 0.00% | -100.0% |
| Q2 2021 | $1,207,000 | -53.4% | 134,057 | -45.1% | 0.00% | 0.0% |
| Q1 2021 | $2,590,000 | +64650.0% | 244,332 | +22842.0% | 0.00% | – |
| Q4 2019 | $4,000 | +300.0% | 1,065 | +163.0% | 0.00% | – |
| Q4 2018 | $1,000 | -99.8% | 405 | -99.4% | 0.00% | – |
| Q3 2018 | $433,000 | -29.6% | 68,528 | -15.7% | 0.00% | – |
| Q2 2018 | $615,000 | +104.3% | 81,338 | +115.9% | 0.00% | – |
| Q1 2018 | $301,000 | +56.0% | 37,680 | +117.9% | 0.00% | – |
| Q4 2017 | $193,000 | -24.9% | 17,292 | -22.2% | 0.00% | – |
| Q3 2017 | $257,000 | – | 22,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 3,056,420 | $22,006,000 | 19.85% |
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $48,300,000 | 17.51% |
| GREAT POINT PARTNERS LLC | 3,448,521 | $24,829,000 | 5.98% |
| Omega Fund Management, LLC | 2,029,580 | $14,613,000 | 5.35% |
| Paradigm Biocapital Advisors LP | 2,214,722 | $15,946,000 | 2.13% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $21,497,000 | 1.66% |
| COMMODORE CAPITAL LP | 1,325,000 | $9,540,000 | 1.53% |
| Octagon Capital Advisors LP | 1,225,000 | $8,820,000 | 1.52% |
| RA Capital Management | 4,356,632 | $31,368,000 | 0.67% |
| TCG Crossover Management, LLC | 254,569 | $1,833,000 | 0.55% |